Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung

Olga Gusliakova, Elena N. Atochina-Vasserman, Olga Sindeeva, Sergey Sindeev, Sergey Pinyaev, Nikolay Pyataev, Viktor Revin, Gleb B. Sukhorukov, Dmitry Gorin, Andrew J. Gow

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Nano- and microencapsulation has proven to be a useful technique for the construction of drug delivery vehicles for use in vascular medicine. However, the possibility of using these techniques within the lung as an inhalation delivery mechanism has not been previously considered. A critical element of particle delivery to the lung is the degree of penetrance that can be achieved with respect to the airway tree. In this study we examined the effectiveness of near infrared (NIR) dye (Cy7) labeled calcium carbonate (vaterite) particles of 3.15, 1.35, and 0.65 μm diameter in reaching the respiratory portion of the lung. First of all, it was shown that, interaction vaterite particles and the components of the pulmonary surfactant occurs a very strong retardation of the recrystallization and dissolution of the particles, which can subsequently be used to create systems with a prolonging release of bioactive substances after the particles penetrate the distal sections of the lungs. Submicro- and microparticles, coated with Cy7 labeled albumin as a model compound, were delivered to mouse lungs via tracheostomy with subsequent imaging performed 24, 48, and 72 h after delivery by in vivo fluorescence. 20 min post administration particles of all three sizes were visible in the lung, with the deepest penetrance observed with 0.65 μm particles. In vivo biodistribution was confirmed by fluorescence tomography imaging of excised organs post 72 h. Laser scanning confocal microscopy shows 0.65 μm particles reaching the alveolar space. The delivery of fluorophore to the blood was assessed using Cy7 labeled 0.65 μm particles. Cy7 labeled 0.65 μm particles efficiently delivered fluorescent material to the blood with a peak 3 h after particle administration. The pharmacokinetics of NIR fluorescence dye will be shown. These studies establish that by using 0.65 μm particles loaded with Cy7 we can efficiently access the respiratory portion of the lung, which represents a potentially efficient delivery mechanism for both the lung and the vasculature.

Original languageEnglish
Article number559
JournalFrontiers in Pharmacology
Volume9
Issue numberJUN
DOIs
Publication statusPublished - 4 Jun 2018

Fingerprint

Calcium Carbonate
Lung
Penetrance
Fluorescence
Pulmonary Surfactants
Drug Compounding
Tracheostomy
Optical Imaging
Cardiology
Confocal Microscopy
Inhalation
Albumins
Coloring Agents
Pharmacokinetics
Tomography
Pharmaceutical Preparations

Keywords

  • Drug carriers
  • Prolonging release
  • Pulmonary drug delivery
  • Size-dependent biodistribution
  • Vaterite particles

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung. / Gusliakova, Olga; Atochina-Vasserman, Elena N.; Sindeeva, Olga; Sindeev, Sergey; Pinyaev, Sergey; Pyataev, Nikolay; Revin, Viktor; Sukhorukov, Gleb B.; Gorin, Dmitry; Gow, Andrew J.

In: Frontiers in Pharmacology, Vol. 9, No. JUN, 559, 04.06.2018.

Research output: Contribution to journalArticle

Gusliakova, Olga ; Atochina-Vasserman, Elena N. ; Sindeeva, Olga ; Sindeev, Sergey ; Pinyaev, Sergey ; Pyataev, Nikolay ; Revin, Viktor ; Sukhorukov, Gleb B. ; Gorin, Dmitry ; Gow, Andrew J. / Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung. In: Frontiers in Pharmacology. 2018 ; Vol. 9, No. JUN.
@article{0acf789d349c471b933f58dfabd31b6a,
title = "Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung",
abstract = "Nano- and microencapsulation has proven to be a useful technique for the construction of drug delivery vehicles for use in vascular medicine. However, the possibility of using these techniques within the lung as an inhalation delivery mechanism has not been previously considered. A critical element of particle delivery to the lung is the degree of penetrance that can be achieved with respect to the airway tree. In this study we examined the effectiveness of near infrared (NIR) dye (Cy7) labeled calcium carbonate (vaterite) particles of 3.15, 1.35, and 0.65 μm diameter in reaching the respiratory portion of the lung. First of all, it was shown that, interaction vaterite particles and the components of the pulmonary surfactant occurs a very strong retardation of the recrystallization and dissolution of the particles, which can subsequently be used to create systems with a prolonging release of bioactive substances after the particles penetrate the distal sections of the lungs. Submicro- and microparticles, coated with Cy7 labeled albumin as a model compound, were delivered to mouse lungs via tracheostomy with subsequent imaging performed 24, 48, and 72 h after delivery by in vivo fluorescence. 20 min post administration particles of all three sizes were visible in the lung, with the deepest penetrance observed with 0.65 μm particles. In vivo biodistribution was confirmed by fluorescence tomography imaging of excised organs post 72 h. Laser scanning confocal microscopy shows 0.65 μm particles reaching the alveolar space. The delivery of fluorophore to the blood was assessed using Cy7 labeled 0.65 μm particles. Cy7 labeled 0.65 μm particles efficiently delivered fluorescent material to the blood with a peak 3 h after particle administration. The pharmacokinetics of NIR fluorescence dye will be shown. These studies establish that by using 0.65 μm particles loaded with Cy7 we can efficiently access the respiratory portion of the lung, which represents a potentially efficient delivery mechanism for both the lung and the vasculature.",
keywords = "Drug carriers, Prolonging release, Pulmonary drug delivery, Size-dependent biodistribution, Vaterite particles",
author = "Olga Gusliakova and Atochina-Vasserman, {Elena N.} and Olga Sindeeva and Sergey Sindeev and Sergey Pinyaev and Nikolay Pyataev and Viktor Revin and Sukhorukov, {Gleb B.} and Dmitry Gorin and Gow, {Andrew J.}",
year = "2018",
month = "6",
day = "4",
doi = "10.3389/fphar.2018.00559",
language = "English",
volume = "9",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "JUN",

}

TY - JOUR

T1 - Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung

AU - Gusliakova, Olga

AU - Atochina-Vasserman, Elena N.

AU - Sindeeva, Olga

AU - Sindeev, Sergey

AU - Pinyaev, Sergey

AU - Pyataev, Nikolay

AU - Revin, Viktor

AU - Sukhorukov, Gleb B.

AU - Gorin, Dmitry

AU - Gow, Andrew J.

PY - 2018/6/4

Y1 - 2018/6/4

N2 - Nano- and microencapsulation has proven to be a useful technique for the construction of drug delivery vehicles for use in vascular medicine. However, the possibility of using these techniques within the lung as an inhalation delivery mechanism has not been previously considered. A critical element of particle delivery to the lung is the degree of penetrance that can be achieved with respect to the airway tree. In this study we examined the effectiveness of near infrared (NIR) dye (Cy7) labeled calcium carbonate (vaterite) particles of 3.15, 1.35, and 0.65 μm diameter in reaching the respiratory portion of the lung. First of all, it was shown that, interaction vaterite particles and the components of the pulmonary surfactant occurs a very strong retardation of the recrystallization and dissolution of the particles, which can subsequently be used to create systems with a prolonging release of bioactive substances after the particles penetrate the distal sections of the lungs. Submicro- and microparticles, coated with Cy7 labeled albumin as a model compound, were delivered to mouse lungs via tracheostomy with subsequent imaging performed 24, 48, and 72 h after delivery by in vivo fluorescence. 20 min post administration particles of all three sizes were visible in the lung, with the deepest penetrance observed with 0.65 μm particles. In vivo biodistribution was confirmed by fluorescence tomography imaging of excised organs post 72 h. Laser scanning confocal microscopy shows 0.65 μm particles reaching the alveolar space. The delivery of fluorophore to the blood was assessed using Cy7 labeled 0.65 μm particles. Cy7 labeled 0.65 μm particles efficiently delivered fluorescent material to the blood with a peak 3 h after particle administration. The pharmacokinetics of NIR fluorescence dye will be shown. These studies establish that by using 0.65 μm particles loaded with Cy7 we can efficiently access the respiratory portion of the lung, which represents a potentially efficient delivery mechanism for both the lung and the vasculature.

AB - Nano- and microencapsulation has proven to be a useful technique for the construction of drug delivery vehicles for use in vascular medicine. However, the possibility of using these techniques within the lung as an inhalation delivery mechanism has not been previously considered. A critical element of particle delivery to the lung is the degree of penetrance that can be achieved with respect to the airway tree. In this study we examined the effectiveness of near infrared (NIR) dye (Cy7) labeled calcium carbonate (vaterite) particles of 3.15, 1.35, and 0.65 μm diameter in reaching the respiratory portion of the lung. First of all, it was shown that, interaction vaterite particles and the components of the pulmonary surfactant occurs a very strong retardation of the recrystallization and dissolution of the particles, which can subsequently be used to create systems with a prolonging release of bioactive substances after the particles penetrate the distal sections of the lungs. Submicro- and microparticles, coated with Cy7 labeled albumin as a model compound, were delivered to mouse lungs via tracheostomy with subsequent imaging performed 24, 48, and 72 h after delivery by in vivo fluorescence. 20 min post administration particles of all three sizes were visible in the lung, with the deepest penetrance observed with 0.65 μm particles. In vivo biodistribution was confirmed by fluorescence tomography imaging of excised organs post 72 h. Laser scanning confocal microscopy shows 0.65 μm particles reaching the alveolar space. The delivery of fluorophore to the blood was assessed using Cy7 labeled 0.65 μm particles. Cy7 labeled 0.65 μm particles efficiently delivered fluorescent material to the blood with a peak 3 h after particle administration. The pharmacokinetics of NIR fluorescence dye will be shown. These studies establish that by using 0.65 μm particles loaded with Cy7 we can efficiently access the respiratory portion of the lung, which represents a potentially efficient delivery mechanism for both the lung and the vasculature.

KW - Drug carriers

KW - Prolonging release

KW - Pulmonary drug delivery

KW - Size-dependent biodistribution

KW - Vaterite particles

UR - http://www.scopus.com/inward/record.url?scp=85048042740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048042740&partnerID=8YFLogxK

U2 - 10.3389/fphar.2018.00559

DO - 10.3389/fphar.2018.00559

M3 - Article

VL - 9

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - JUN

M1 - 559

ER -